Wildfires are devastating communities across California, causing more than 300,000 people to evacuate their homes and threatening many more. The Camp Fire in Northern California -- one of three blazing across the state -- is the most destructive in state history. We want to ensure that, if you are in an affected community, you find access to shelter. And if you are looking to help with disaster relief efforts, you know the most effective ways to contribute.
ALS Therapy Development Foundation IncALS Therapy Development Foundation Inc
The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that stop ALS as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-... Read more
The mission of the ALS Therapy Development Institute (ALS TDI) is to develop effective therapeutics that stop ALS as soon as possible. Focused on meeting this urgent unmet medical need, ALS TDI executes a robust discovery program, as well as a multi-pronged approach to validate potential therapeutics; including small molecules, protein biologics, gene therapies and cell-based constructs. The Institute's unique, industrial-scale platform allows for the development and testing of dozens of potential therapeutics each year.
ALS TDI combines the passion and dedication of a nonprofit organization with the entrepreneurial and scientific spirit of a biotechnology company
Our laboratory, the leading drug discovery program for ALS, bridges a critical research gap
Our in-house expertise translates research into potential drug candidates by screening drugs in the SOD1 mouse model of ALS.
Our scientific collaborations are designed to bring the most promising leads closer to patient use.
We share emerging knowledge on the disease with patients, physicians, and researchers as quickly and comprehensively as possible.
Every decision is made in the interest of finding effective treatments for people living with ALS.
Our unique approach accelerates drug development for ALS.